Skip to main content
. 2021 Nov 10;28(1):2392–2414. doi: 10.1080/10717544.2021.1998246

Table 2.

Examples of the currently available antimicrobial therapy targeting osteomyelitis causative pathogens with the systemic route of administration.

Microorganism Antimicrobial agent Route Products approved by the FDA Date of approval
Methicillin- resistant staphylococcus aureus (MRSA) Vancomycin IV Firvanq® 2018
Vancomycin® 1999
Tedizolid IV/ Oral Sivextro® 2014
Daptomycin IV Cubicin® 2003
Linezolid IV/ Oral Zyvox® 2000
Trimethoprim/sulfamethoxazole
(+oral Rifampin)
IV Sulfamethoxazole and trimethoprim® 1991
Oral Sulfamethoxazole and trimethoprim® 1986
Clindamycin IV Cleocin phosphate® 1972
Oral Cleocin hydrochloride ® 1970
Methicillin- sensitive staphylococcus aureus (MSSA) Cefazolin IV Cefazolin sodium® 1988
Nafcillin/oxacillin IV Unipen® 1970
P. aeruginosa Levofloxacin Oral Levofloxacin® 2011
IV Levofloxacin® 2005
Ciprofloxacin IV Ciprofloxacin® 2009
Oral Ciprofloxacin® 2004
Meropenem IV Merrem® 1996
Cefepime IV Maxipime® 1996
Piperacillin/tazobactam IV Zosyn® 1993
Ceftazidime IV Fortaz® 1985
Imipenem/cilastin IV Primaxin® 1985
Enterobacteriaceae Moxifloxacin
(+antipseudomonal agents)
IV/oral Moxifloxacin hydrochloride® 2015
Ceftriaxone IV Cftriaxone® 2003
Cefotaxime IV Cefotaxime sodium® 2002
Enterobacteriaceae
(Anaerobes)
Clindamycin IV/oral Cleocin phosphate® 1999
Cleocin HCL® 1998
Metronidazole Oral Flagyl® 1995
IV Flagyl® 1981
Enterococcus spp.
(Ampicillin resistant)
Vancomycin IV Firvanq® 2018
Vancomycin® 1999
Enterococcus spp.
(Ampicillin sensitive)
Ampicillin/ sulbactam IV Unasyn® 1986
Enterococcus spp.
(Vancomycin resistant)
Tedizolid IV/oral Sivextro® 2014
Linezolid IV/ oral Zyvox® 2007
Daptomycin IV Cubcin® 2003
Streptococcus spp. Penicillin G IV Bicillin L-A® 1952